The Inappropriate Use of GLP-1 Analogs: Reflections from Pharmacoepidemiology

The Inappropriate Use of GLP-1 Analogs: Reflections from Pharmacoepidemiology

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as a potent therapeutic option for the management of obesity, demonstrating exceptional efficacy in several large-scale clinical trials. Despite their promising therapeutic outcomes, the rising popularity of these agents raises signi...

Full description

Saved in:
Bibliographic Details
Main Authors: Sofía Echeverry-Guerrero, Salomé González-Vélez, Ana-Sofía Arévalo-Lara, Juan-Camilo Calvache-Orozco, Sebastián Kurt Villarroel-Hagemann, Luis Carlos Rojas-Rodríguez, Andrés M. Pérez-Acosta, Carlos-Alberto Calderon-Ospina
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Pharmacoepidemiology
Subjects:
glucagon-like peptide-1 receptor agonists
semaglutide
exenatide
liraglutide
dulaglutide
lixisenatide
Online Access:https://www.mdpi.com/2813-0618/3/4/25
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2813-0618/3/4/25

Similar Items